Bronchodilators Flashcards
Beta2- Adrenergic Agonists- Terols MOA
Activation of the beta2-adrenergic receptors- promote bronchodilation and relieve bronchospams
- additional role in suppressing histamine release and increasing ciliary motility
Beta2- Adrenergic Agonists- LABA
-use
Used on a fixed schedule to prevent exacerbations- must always be combined with an inhaled ICS in asthma use- monotherapy a/w increased incidence as asthma-related death
Beta2- Adrenergic Agonists- SABA
Used to abort an ongoing attack or prior to exercise to prevent EIB (exercise induced bronchoconstriction)- nebulized in hospitalized patients
Beta2- Adrenergic Agonists- use
Most effective drugs available for relieving acute bronchospasm and preventing exercise induced bronchospams
-virtually all patients with asthma use these as first line agents
ADR Beta2- Adrenergic Agonists-
1) tachycardia
2) angina
3) tremor
4) nervousness
5) excitement
Albuterol indications and drug class
bronchospasm, exercise induced bronchospasm
-SABA
moa albuterol
beta 2 agonist
short acting
Levalbuterol as compared to albuterol
initially thought to have less jitters, tachycardia- not proven but may be the case on some patients
-SABA
Long acting beta agonists (LABA) types
formoterol
salmeterol
rarely used as a monotherapy
Muscarinic antagonists (anticholinergics) use
Historically only approved for COPD but were used off label for asthma for years- have slowly been gaining approvals for asthma (typically the combo products)
MOA of anticholinergics
1) antagonists at muscarinic receptor in the bronchi- reduce bronchoconstriction
SAMA
- use
- dose
Shorter duration of action and faster onset- used for attacks (COPD exacerbation)- often combined with albuterol. Typically 4x/day inhalations
example: ipratropium
LAMA
- use
- dose
Similar to LABAs- used more control and long term prophylaxis/prevention- typically 1-2 times per day inhalations
ADR of anticholinergics
Dry mouth (anticholinergic effect), irritation of the pharynx, urinary retention
Ipratropium (atrovent) MOA and drug class, indications
- short acting muscarinic antagonist
- SAMA
- used for COPD